PepGen (NASDAQ:PEPG – Get Free Report) and Sage Therapeutics (NASDAQ:SAGE – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, valuation, profitability, risk and dividends. Earnings & Valuation This table compares PepGen and […]
Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Wedbush upped their Q2 2024 earnings estimates for Sage Therapeutics in a note issued to investors on Thursday, April 25th. Wedbush analyst L. Chico now anticipates that the biopharmaceutical company will post earnings of ($1.83) per share for the quarter, up from their prior forecast of ($2.00). […]
Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Wedbush decreased their Q1 2024 earnings per share estimates for shares of Sage Therapeutics in a report released on Wednesday, April 17th. Wedbush analyst L. Chico now forecasts that the biopharmaceutical company will earn ($1.92) per share for the quarter, down from their previous estimate of ($1.89). […]
Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Stock analysts at Wedbush dropped their Q1 2024 earnings estimates for shares of Sage Therapeutics in a research note issued on Wednesday, April 17th. Wedbush analyst L. Chico now expects that the biopharmaceutical company will post earnings of ($1.92) per share for the quarter, down from their […]